TCAR | sciencenewsnet.in

Breaking News

Perceived Communications Positively Impact Grief and Grieving

Scientists Discover Mechanism of Sugar Signaling in Plants

Gut bacteria boost immune response to fight tumors

NUS scientist Professor Lim Chwee Teck elected Fellow of the Royal Society

Rutgers Researchers Identify Impacts of Russia-Ukraine War on Hospitals

Cleveland Clinic ReCOVer Clinic now enrolling Long COVID patients in the NIH RECOVER-VITAL clinical study.

Link between e-cigarette use and early age of asthma onset in U.S. adults found through UTHealth Houston research

NJIT Researcher: Neural Networks Can Mediate Between Download Size and Quality

IU School of Medicine researchers to present respiratory therapy advancements at ATS 2024

Collaborative Partnership to Address Mental Health Gap Affecting Our Homeless Community Members

18 May, 2024

Hackensack University Medical Center Becomes Only Hospital in New Jersey to Offer Transcarotid Artery Revascularization (TCAR) Clinical Trial

April 4, 2023 sarah JonasFeature

Hackensack University Medical Center is the only site in New Jersey that is participating in the ROADSTER 3 clinical trial to assess real-world outcomes for patients with carotid artery disease who have an average surgical risk and undergo a minimally invasive surgical procedure called transcarotid artery revascularization (TCAR).